These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25159240)

  • 21. Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.
    Zeller M; Labalette-Bart M; Juliard JM; Potier L; Feldman LJ; Steg PG; Cottin Y; Roussel R
    Int J Cardiol; 2016 Oct; 220():137-42. PubMed ID: 27376570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.
    Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure is the strongest predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Matějka J; Varvařovský I; Rozsíval V; Herman A; Bláha K; Večeřa J; Lazarák T; Novotný V; Mužáková V; Vojtíšek P
    Kardiol Pol; 2016; 74(1):18-24. PubMed ID: 26101023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial.
    Crimi G; Leonardi S; Costa F; Ariotti S; Tebaldi M; Biscaglia S; Valgimigli M
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):E19-27. PubMed ID: 25703119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
    Tsai TT; Patel UD; Chang TI; Kennedy KF; Masoudi FA; Matheny ME; Kosiborod M; Amin AP; Messenger JC; Rumsfeld JS; Spertus JA
    JACC Cardiovasc Interv; 2014 Jan; 7(1):1-9. PubMed ID: 24456715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editor's Choice- What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?
    Auer J; Verbrugge FH; Lamm G
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):739-742. PubMed ID: 28849947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography.
    Guillon B; Ecarnot F; Marcucci C; Ducloux D; Chatot M; Badoz M; Bonnet B; Chopard R; Frey P; Meneveau N; Schiele F
    Am J Cardiol; 2018 Apr; 121(7):818-824. PubMed ID: 29397881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury is associated with microvascular myocardial damage following myocardial infarction.
    Reinstadler SJ; Kronbichler A; Reindl M; Feistritzer HJ; Innerhofer V; Mayr A; Klug G; Tiefenthaler M; Mayer G; Metzler B
    Kidney Int; 2017 Sep; 92(3):743-750. PubMed ID: 28412022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mandurino-Mirizzi A; Kajana V; Cornara S; Somaschini A; Demarchi A; Galazzi M; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2140-2143. PubMed ID: 34039505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention.
    Liu YH; Liu Y; Tan N; Chen JY; Chen J; Chen SH; He YT; Ran P; Ye P; Li Y
    Int Urol Nephrol; 2014 Feb; 46(2):417-26. PubMed ID: 24265037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y; Maekawa Y; Miyata H; Inoue S; Ishikawa S; Sueyoshi K; Noma S; Kawamura A; Kohsaka S; Fukuda K
    J Am Coll Cardiol; 2013 Oct; 62(14):1260-1266. PubMed ID: 23770181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction.
    Baek JY; Seo SM; Park HJ; Kim PJ; Park MW; Koh YS; Chang KY; Jeong MH; Park SJ; Seung KB
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):E243-50. PubMed ID: 22105969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
    Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: a randomized controlled trial.
    Yamanaka T; Kawai Y; Miyoshi T; Mima T; Takagaki K; Tsukuda S; Kazatani Y; Nakamura K; Ito H
    Int J Cardiol; 2015 Jan; 178():136-41. PubMed ID: 25464237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.